dr.rajinikanth - Neuome Technologies

Dr. Rajanikanth Vangala

(CEO-Neuome Technologies (P). Ltd, India, Co-Founder Neuome. Peptides (P), Ltd, Singapore. Ph.D Human Biology-LMU Munich Germany, PDF-Karolinska. Institute Sweden, Scientist-Hammersmith Hospital. Imperial College London UK)

brief about dr. Rajanikanth vangala

Linkedin Dr. Rajanikanth Vangala (CEO-Neuome Technologies (P). Ltd, India, Co-Founder Neuome Peptides (P), Ltd, Singapore. Ph.D Human Biology-LMU Munich Germany, PDF-Karolinska Institute Sweden, Scientist-Hammersmith Hospital Imperial College London UK) Dr Rajani completed his Ph.D from Department of Medicine III, Klinikum Grosshardern, LMU, Munich, and post-doctoral work at the Center for Genomics and Bioinformatics, Karolinska Institute, […]

education
experience
activities
papers published

Co-Founder and CEO , Neuome Technologies Private Limited April 2020-Present
Founder Director, Institute for Applied Research and Innovation (InARI) 2018-Present
Head Translational Research, Thrombosis Research Institute, Bangalore, Jan 2011-Feb 2018
Applied Biotechnology - Faculty Scientist, Institute of Bioinformatics and Applied Biotechnology Aug 2010 - Jun 2011
Managing Director InnovoBiologicals Pvt. Nov 2008 - Dec 2010

The myeloid master regulator transcription factor PU. 1 is inactivated by AML1-ETO in t (8; 21) myeloid leukemia RK Vangala, MS Heiss-Neumann, JS Rangatia, SM Singh, C Schoch, ... Blood 101 (1), 270-277 2003
The myeloid master regulator Pu. 1 is inactivated by Aml1-eto in t (8; 21) myeloid leukemia RK Vangala, MS Neumann, JS Rangatia, SM Singh, C Schoch, DG Tenen, ... Onkologie 25, 262 2002
Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU. 1: possible role in lineage commitment decisions VA Reddy, A Iwama, G Iotzova, M Schulz, A Elsasser, RK Vangala, ... Blood 100 (2), 483-490 2002
Downregulation of c-Jun expression by transcription factor C/EBPα is critical for granulocytic lineage commitment J Rangatia, RK Vangala, N Treiber, P Zhang, H Radomska, DG Tenen, ... Molecular and cellular biology 22 (24), 8681-8694 2002
downregulation of c-jun expression by transcription factor C/ebpalpha is critical for granulocytic lineage commitment: 569 J Rangatia, RK Vangala, N Treiber, P Zhang, DG Tenen, W Hiddemann, ... Onkologie 25, 161 2002
Association of γ-glutamyl transferase with premature coronary artery disease M Ghatge, A Sharma, RK Vangala Biomedical reports 4 (3), 307-312 2016
Integrative bioinformatics analysis of genomic and proteomic approaches to understand the transcriptional regulatory program in coronary artery disease pathways RK Vangala, V Ravindran, M Ghatge, J Shanker, P Arvind, H Bindu, ... PloS one 8 (2), e57193 2013
BioParishodhana: A novel graphical interface integrating BLAST, ClustalW, primer3 and restriction digestion t00ls RK Vangala, L Singh, RP Gupta Bioinformation 8 (13), 639 2012
Modulation of clinically relevant pathways by post translation modification regulatory system in coronary artery disease RK Vangala, A Sharma, M Ghatge Journal of Thrombosis and Haemostasis 13, 96 2015
In-silico to in-vivo proteomics of AML1-ETO interacting proteins in t (8; 21)-AML. RK Vangala, DG Tenen, W Hiddemann, G Behre BLOOD 98 (11), 834A-834A 2001

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Dr. Rajanikanth Vangala

(CEO-Neuome Technologies (P). Ltd, India, Co-Founder Neuome. Peptides (P), Ltd, Singapore. Ph.D Human Biology-LMU Munich Germany, PDF-Karolinska. Institute Sweden, Scientist-Hammersmith Hospital. Imperial College London UK)

brief about dr. Rajanikanth vangala

Subscribe To Our Newsletter

Address

Call Us

Email Us

Useful Links

Follow Us